ANDE Stock Analysis: The Andersons | NASDAQ
Food Distribution | NASDAQ, USA | Market Cap: 2.225m USD | 12M Return: 66.3% | US0341641035 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 23.4M
EPS Trend: 42.6%
Qual. Beats: 4
Rev. Trend: -84.5%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Andersons, Inc. (NASDAQ: ANDE) is a U.S.-headquartered agriculture and renewable fuels company founded in 1947 and based in Maumee, Ohio, operating across the United States, Canada, Mexico, and select international markets. The company is organized into two business segments: Agribusiness, which merchandises commodity grains (corn, wheat, soybeans), manufactures and distributes agricultural plant nutrients and fertilizers, and provides logistics services for physical agricultural commodities; and Renewables, which produces, purchases, sells, and trades ethanol, co-products, and other renewable feedstocks and biofuels.
Despite its GICS classification under Consumer Staples / Food Distributors, ANDEs revenue base is largely tied to commodity grain merchandising and ethanol production-two capital-intensive, margin-sensitive segments whose performance is heavily influenced by U.S. crop yields, weather, and federal renewable fuel policies such as the Renewable Fuel Standard (RFS), which mandates blending of biofuels like ethanol into the U.S. gasoline supply.
- Ethanol margins pressured by corn input costs
- Grain merchandising volume swings with harvest cycles
- Plant nutrient pricing volatility affects segment margins
| Net Income: 177.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.86 > 1.0 |
| NWC/Revenue: 6.42% < 20% (prev 9.49%; Δ -3.06% < -1%) |
| CFO/TA 0.09 > 3% & CFO 321.9m > Net Income 177.3m |
| Net Debt (905.8m) to EBITDA (375.5m): 2.41 < 3 |
| Current Ratio: 1.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (34.3m) vs 12m ago 0.33% < -2% |
| Gross Margin: 7.87% > 18% (prev 6.30%; Δ 1.57% > 0.5%) |
| Asset Turnover: 316.1% > 50% (prev 334.8%; Δ -18.69% > 0%) |
| Interest Coverage Ratio: 3.56 > 6 (EBIT TTM 206.8m / Interest Expense TTM 58.1m) |
| A: 0.20 (Total Current Assets 2.08b - Total Current Liabilities 1.38b) / Total Assets 3.47b |
| B: 0.32 (Retained Earnings 1.11b / Total Assets 3.47b) |
| C: 0.06 (EBIT TTM 206.8m / Avg Total Assets 3.46b) |
| D: 0.62 (Book Value of Equity 1.32b / Total Liabilities 2.12b) |
| Altman-Z'' = 3.43 = A |
| DSRI: 1.02 (Receivables 755.2m/783.9m, Revenue 10.9b/11.5b) |
| GMI: 0.80 (GM 6.30% / 7.87%) |
| AQI: 1.06 (AQ_t 0.12 / AQ_t-1 0.11) |
| SGI: 0.95 (Revenue 10.9b / 11.5b) |
| TATA: -0.04 (NI 177.3m - CFO 321.9m) / TA 3.47b) |
| Beneish M = -3.20 (Cap -4..+1) = AA |
As of August 13, 2026, the stock is trading at USD 65.61 with a total of 276,848 shares traded. Over the past week, the price has changed by -5.94%, over one month by -12.27%, over three months by -6.54% and over the past year by +66.32%.
Current recommended Stop Loss: 60.00 (which is 8.6% or 1.9 ATR below the current price).
The Andersons has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy ANDE.
- StrongBuy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 88.3 | 34.6% |
P/E Trailing = 12.6429
P/E Forward = 20.9205
P/S = 0.2034
P/B = 1.6847
P/EG = 0.8947
Revenue TTM = 10.9b USD
EBIT TTM = 206.8m USD
EBITDA TTM = 375.5m USD
Long Term Debt = 563.5m USD (from longTermDebt, last quarter)
Short Term Debt = 337.3m USD (from shortTermDebt, last quarter)
Debt = 972.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 71.5m
Net Debt = 905.8m USD (calculated: Debt 972.3m - CCE 66.5m)
Enterprise Value = 3.13b USD (2.23b + Debt 972.3m - CCE 66.5m)
Interest Coverage Ratio = 3.56 (Ebit TTM 206.8m / Interest Expense TTM 58.1m)
EV/FCF = 55.01x (Enterprise Value 3.13b / FCF TTM 56.9m)
FCF Yield = 1.82% (FCF TTM 56.9m / Enterprise Value 3.13b)
FCF Margin = 0.52% (FCF TTM 56.9m / Revenue TTM 10.9b)
Net Margin = 1.62% (Net Income TTM 177.3m / Revenue TTM 10.9b)
Gross Margin = 7.87% ((Revenue TTM 10.9b - Cost of Revenue TTM 10.1b) / Revenue TTM)
Gross Margin QoQ = 7.22% (prev 8.96%)
Tobins Q-Ratio = 0.90 (Enterprise Value 3.13b / Total Assets 3.47b)
Interest Expense / Debt = 5.98% (Interest Expense 58.1m / Debt 972.3m)
Taxrate = 15.94% (34.2m / 214.7m)
NOPAT = 173.8m (EBIT 206.8m * (1 - 15.94%))
Current Ratio = 1.51 (Total Current Assets 2.08b / Total Current Liabilities 1.38b)
Debt / Equity = 0.74 (Debt 972.3m / totalStockholderEquity, last quarter 1.32b)
Debt / EBITDA = 2.41 (Net Debt 905.8m / EBITDA 375.5m)
Debt / FCF = 15.91 (Net Debt 905.8m / FCF TTM 56.9m)
Total Stockholder Equity = 1.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.12% (Net Income 177.3m / Total Assets 3.47b)
RoE = 14.15% (Net Income TTM 177.3m / Total Stockholder Equity 1.25b)
RoCE = 11.38% (EBIT 206.8m / Capital Employed (Equity 1.25b + L.T.Debt 563.5m))
RoIC = 7.35% (NOPAT 173.8m / Invested Capital 2.37b)
WACC = 6.96% (E(2.23b)/V(3.20b) * Re(7.80%) + D(972.3m)/V(3.20b) * Rd(5.98%) * (1-Tc(0.16)))
Discount Rate = 7.80% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -1.80 | Cagr: -0.78%
[DCF] Terminal Value 77.97% ; FCFF base≈44.9m ; Y1≈51.4m ; Y5≈75.7m
[DCF] Fair Price = 6.88 (EV 1.14b - Net Debt 905.8m = Equity 233.6m / Shares 34.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 42.63 | EPS CAGR: 11.96% | SUE: 2.62 | # QB: 4
Revenue Correlation: -84.54 | Revenue CAGR: -11.50% | SUE: -0.44 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.07 | Chg30d=+8.82% | Revisions=+25% | Analysts=3
EPS current Year (2026-12-31): EPS=6.11 | Chg30d=+11.70% | Revisions=+25% | GrowthEPS=+89.2% | GrowthRev=+5.6%
EPS next Year (2027-12-31): EPS=6.27 | Chg30d=+5.20% | Revisions=+25% | GrowthEPS=+2.7% | GrowthRev=+2.4%
[Analyst] Revisions Ratio: +50% (up=3, down=0)